Transcript Slide 1

Establishing the psychometric properties of
measures of suicidal ideation and attempts
Jill Harkavy-Friedman, PhD
Reasons to Assess Suicidal ideation
and attempts in Clinical Trials
Adverse Event

Did the event occur during the trial
Focus of treatment
Did the behavior change during the trial
 Define change relative to baseline levels

There is a need for different assessment tools
Dilemma: How to standardize
across studies
Have well defined universal criterion that represents
goal of assessment

Final universal criterion must have established
psychometric properties and clinical utility
Study Measures



Permit classification with universal criterion
Measures must have established psychometric properties
An independent rater can make categorization to universal
criterion using results of the specific measure
How to chose an instrument
Multiple factors that lead to choice of measure







Who: Patients, controls
What: Ideation, attempts, suicides
Where: Office, home, phone/computer
When: Baseline, Weekly, Discharge, Follow-Up
Why: Adverse event; Reduction of behavior
How: Interview (clinical or lay), questionnaire
Feasibility: Cost, time, personnel
Choosing the variable of
interest?
Based on goal of study & review of literature

Impact/Importance of variable
Thoughts of death, Suicidal ideation, Suicide attempt, Suicide
Absolute value or change score


Did suicidal ideation or attempt occur during trial?
Did suicidal ideation or number of attempts change during trial?
Emergent suicidal ideation and attempts behavior in non-suicidal
sample
In high risk samples requires pre-post assessment using prospective
design to demonstrate change
Multiple measures vs. single measure

Suicidal ideation and attempts in context of risk factors vs.
suicidal behavior alone
Depression, substance use, stress, psychosis
Psychometrics
Evaluate the psychometric properties
Reliability
 Validity
 Sensitivity
 Specificity
 Variability
 Ceiling and Floor effects

RELIABILITY=REPRODUCABILITY
Inter-rater Reliability
If 2 or more of us
collect and/or see the
same information will
we make the same
rating.
Kappa: Categorical

(attempt/no attempt)
Intra-class correlation:

Numerical (Total score)
Test-Retest: Over time
Correlate time 1 and time 2
If we measure today and
measure tomorrow will
we get the same answer.
Parallel Forms: Across
Measurements
Correlate forms
Avoid learning effects
due to repeated
assessments
Internal Consistency: Within a
test
Are the items of a
measure assessing a
single content or
construct?
Split-Half
Spearman Brown
Cronbach’s Alpha
What does the number mean?
Range: 0-1.0

reliability2=
percent of variance accounted for
by measure (the rest is random
error or due to other factors)
0-.30 - weak
 .31-.69 - moderate
 .70-1.0 - strong (accounts for 50% of variance or more)

Validity
Face Validity: Does it look like it measures what it is
supposed to ?
Content Validity: Is the content representative?
Criterion Validity: Predictive, Concurrent
Construct Validity: Accrual of meaning through
convergent and discriminant validity
Content Validity: Is the content
representative?
What forms of suicidal behavior are of interest

Ideation
Frequency
Planfulness
Persistence
Intent

Preparatory Behaviors
Aborted Attempt
Interrupted Attempt


Attempt
Self-Injurious Behavior
Criterion Validity: Predictive,
Concurrent
Predictive Validity

Does the measure predict future criterion
Requires prospective design
Sensitivity and Specificity for future suicidal behavior
Concurrent Validity

Does the measure relate to variables it ought to relate to
at the time of assessment
90+% of people who suicide have a diagnosable psychiatric
condition- are you sure behavior in study is due to the medication
being tested
Depression, Substance Use, Aggression, Impulsiveness, Psychosis
Construct Validity: Accrual of
meaning through convergent and
discriminant validity
Validity is accrued
Convergent Validity

Does the measure related to what it ought to
Depression, substance use, stress, health, psychosis
Discriminant Validity

Is the measure independent of variables not related
to suicidal behavior (e.g. positive life events)
RELIABILITY IS THE UPPER LIMIT OF
VALIDITY
Can you find an effect?
Sensitivity and Specificity
Variability
Ceiling and Floor effects
Sensitivity and Specificity

sensitivity = probability of a positive test among
patients with disease

specificity = probability of a negative test among
patients without disease
Example study establishing
psychometric properties
Goal: Establish the psychometric properties of a self-report measure of suicidal
ideation and attempts
Sample:
 Psychiatric clinic sample without controlling for diagnosis
Measures:
 Universal Criterion: measure requiring trained interviewer to determine no
suicidal behavior/suicidal ideation/suicide attempt in past week
 Self-report questionnaire of suicidal ideation and attempts over past week
 SxList: assesses psychopathology associated with behavior
 SubUse: assesses substance use
 LifeList: assesses positive and negative stress
Procedures:



Patient completes all self-report measures
Patient is interviewed by clinical interviewer who categorizes suicidal
behavior
Patient returns 2-3 days later and completes suicidal behavior questionnaire
Initial Data Analysis:






Frequency distribution of items, total score and Universal Criterion from
suicidal ideation and attempts questionnaire
Internal consistency of suicidal ideation and attempts questionnaire
Correlate suicidal ideation and attempts questionnaire from time 1 and time 2
Compare categorization by questionnaire vs. clinical rater
Examine relationships of questionnaire and interviewer ratings with additional
measures using multi-method multi-trait matrix
Examine sensitivity and specificity of questionnaire relative to interviewer
categorization
Considerations for assessing
suicidal behavior in clinical trials
Suicidal ideation and attempts are multiply determined, intermittent and
often recurrent
Measures in clinical trials can include categorization into universal
criterion that can be used across studies
Goal of the clinical trial plays an integral role in determining:






Should suicidal ideation and attempts be measured?
How will suicidal ideation and attempts be measured?
When should suicidal ideation and attempts be measured?
How will Adverse Events be measured?
When suicidal ideation and attempts are assessed should associated risk
factors also be assessed (at least at baseline)?
Can evaluate possible causal link to Adverse Event?
Validity is accrued across studies